Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Morepen Laboratories

Morepen Laboratories
1984 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
500288 STOCK SYMBOL
$0.22 SHARE PRICE (As of Thursday Closing)
Description

Morepen Laboratories Ltd is an India based pharmaceutical company. It develops, manufactures and markets generic drugs and pharmaceutical formulations. The company's products include tablets, capsules, injections, ointments, syrups, and powders. It also offers products under brands Burnol, Lemolate and Fiber-X. The company's geographical markets include India, the United States and the rest of the world, with the majority of the revenue generated from India.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Primary Office
  • 409, Antriksh Bhawan
  • 22 Kasturba Gandhi Marg
  • New Delhi, Delhi 110001
  • India

+91 098183 00000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Morepen Laboratories’s full profile, request a free trial.

Morepen Laboratories Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.18 - $0.35 $98.8M $0.22 124K 450M

Morepen Laboratories Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 106,797 107,767 219,905 137,576
Revenue 120,214 109,803 94,074 88,775
EBITDA 11,055 9,983 10,523 9,616
Net Income 4,404 4,122 4,590 3,524
Total Assets 97,412 88,579 89,980 83,004
Total Debt 2,245 1,720 2,337 8,950
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Morepen Laboratories Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Morepen Laboratories‘s full profile, request access.

Request full access to PitchBook

Morepen Laboratories Executive Team (1)

Name Title Board
Seat
Contact
Info
Varun Suri Chief Executive Officer